Form 4: Sight Sciences CLO Sells Shares for Tax
Insider Transaction Report
Sight Sciences' Chief Legal Officer, Jeremy B. Hayden, sold 6,308 shares of common stock at a weighted average price of $6.62 to cover tax liabilities from RSU vesting.
Summary
- Jeremy B. Hayden, Chief Legal Officer of Sight Sciences, Inc. (SGHT), reported the sale of 6,308 shares of the company's common stock.
- The transaction occurred on January 16, 2026, and was executed pursuant to a Rule 10b5-1 plan.
- The shares were sold at a weighted average price of $6.62, with individual transaction prices ranging from $6.44 to $6.69.
- The purpose of the sale was to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units (RSUs).
- Following this transaction, Mr. Hayden beneficially owns 267,611 shares, which includes 75,562 shares of common stock and 192,049 shares underlying unvested RSUs.
- The filing corrects previous reporting errors, now including 39,825 RSU shares that were inadvertently excluded from prior beneficial ownership reports.
- Additionally, 11,326 shares of common stock underlying stock options that were to vest within 60 days were inadvertently included in a February 16, 2024 Form 4 and are now correctly excluded from the reported balance.
Sentiment
Score: 5
Explanation: This filing reports a routine insider transaction (sale to cover tax liability from RSU vesting) and includes corrections to previously reported beneficial ownership, which are administrative in nature and do not indicate a positive or negative sentiment regarding the company's performance or outlook.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction, specifically a sale of shares to cover tax obligations related to RSU vesting. Such transactions are common for executives receiving equity compensation and typically do not reflect broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders: The sale is a routine tax-related transaction by an insider and is unlikely to have a significant impact on shareholder perception or the company's stock price. The correction of previous reporting errors improves transparency.
Key Dates
| Date | Description |
|---|---|
| 02/09/2022 | Date of RSU grant (12,000 RSUs) to the Reporting Person. |
| 02/11/2022 | Form 4 filed reporting the 12,000 RSU grant. |
| 01/05/2023 | Form 4 filed, which subsequently included the 12,000 RSU grant under Table 1. |
| 03/16/2023 | Date of RSU grant (45,100 RSUs) to the Reporting Person. |
| 03/21/2023 | Form 4 filed reporting the 45,100 RSU grant. |
| 02/16/2024 | Form 4 filed that inadvertently included 11,326 shares of common stock underlying stock options. |
| 01/16/2026 | Date of transaction: sale of 6,308 shares of common stock. |
| 01/21/2026 | Signature date of the current Form 4 filing. |
Keywords
Sight Sciences, SGHT, Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, Tax Liability, Jeremy B. Hayden, Chief Legal Officer, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.